In a study of chemokine CXC motif ligand 12 (CXCL12), a prognosis factor similar to IDO1, a high CXCL12 expression was associated with a shorter OS in esophagogastric, pancreatic, or lung cancer, while the opposite was the case for breast cancer (62). Here, IDO1 is linked to breast cancer.